• Department of Disease Control, Minister of Health China, National Center for AIDS Prevention and Control, Group of National HIV Sentinel Surveillance. National sentinel surveillance of HIV infection in China from 1995 to 1998[J]. Chin J Epidemiol, 2000, 21(): 7-9.

  • Gherardi M M, Ramirez J C, Esteban M. Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens[J]. Histol Histopathol, 2001, 6(2): 655-667.

  • Letvin N L. Progress in the development of an HIV-1 vaccine[J]. Science, 1998, 280(5371): 1875-1880. doi: 10.1126/science.280.5371.1875

  • Malkevitch N V, Robert-Guroff M. A call for replicating vector prime-protein boost strategies in HIV vaccine design[J]. Expert Rev Vaccines, 2004, 3(4 Suppl): 105-117.

  • Ma Y, Li Z, Zhao S D. HIV infected people were first identified in Intravenous drug users in China[J]. Chin J Epidemiol, 1990, 11(): 184-185.

  • Peng B, Wang L R, Gomez-Roman V R. Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies[J]. J Virol, 2005, 79(16): 10200-10209. doi: 10.1128/JVI.79.16.10200-10209.2005

  • State Council AIDS Working Committee Office and UN Theme Group on HIV/AIDS in China. 2004. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2004).

  • The Ministry of Health, National Development and Reform Commission, The Ministry of Science and Technology, and The Ministry of Finance of People's Republic of China. 1998. Chinese Middle and Long Period AIDS Prevention and Control Programme (1998-2010).

  • The Ministry of Health of the People's Republic of China, Joint United Nations Programme on HIV/AIDS and World health Organization. 2006. 2005 Update on the HIV/AIDS Epidemic and Response in China.

  • Wu Z, Sun X, Sullivan S G. HIV testing in China[J]. Science, 2006, 312(): 1475-1476. doi: 10.1126/science.1120682

  • Xing H, Jiang S, Si X, et al. 2005. HIV-1 drug resistance in China: nation-wide survey and analysis of impacting factors in the national ARV treatment program. TuPp0302, 3rd IAS conference on HIV Pathogenesis and Treatment, Rio de Janeiro.

  • Zeng Y, Fan J, Zhang Q. Detection of antibody to LAV/HTLV-Ⅲ in sera from hemophiliacs in China[J]. AIDS Res, 1986, 2(Suppl1): 147-149.

  • Zheng X. Control of transmission of HIV among drug users and commercial blood donors[J]. Chin J Epidemiol, 2000, 21(): 6-.

  • Zheng X, Wang Z, Xu J. The epidemiological study of HIV infection among paid blood donors in one county of China[J]. Chin J Epidemiol, 2000, 21(): 253-255.